Prior history of allergies and pancreatic cancer in the San Francisco Bay Area

被引:80
作者
Holly, EA
Eberle, CA
Bracci, PM
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94118 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[3] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
关键词
allergy and immunology; pancreatic neoplasms;
D O I
10.1093/aje/kwg174
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Data from a large population-based case-control study conducted in the San Francisco Bay Area between 1994 and 2001 were analyzed to examine the association between pancreatic cancer and history of allergic conditions. Pancreatic cancer cases (n=532) had to be 21-85 years of age and were identified using rapid case ascertainment. Random digit dialing and Health Care Financing Administration lists (age, greater than or equal to65 years) were used to obtain 1,701 controls who were frequency-matched to cases by sex and age within 5 years. In-person interviews were conducted and detailed allergy history data were obtained for all participants. Prior history of any allergy was associated with a reduced risk estimate for pancreatic cancer (odds ratio (OR)=0.77, 95% confidence interval (CI): 0.63, 0.95). Inverse associations were observed for common allergens, including house dust (OR=0.72, 95% CI: 0.54, 0.94), cats (OR=0.59, 95% CI: 0.41, 0.85), plants (OR=0.77, 95% CI: 0.62, 0.96), and mold (OR=0.49, 95% CI: 0.32, 0.75), and for all allergic symptoms, although some confidence intervals included unity. Trends were observed for decreased risks associated with increasing number of allergies (p=0.0006) and severity of allergic symptoms (p=0.003). These results provide support for the plausibility that immune function in relation to allergies may play a role in the etiology of pancreatic cancer.
引用
收藏
页码:432 / 441
页数:10
相关论文
共 54 条
[1]  
[Anonymous], 1996, Cancer epidemiology and prevention
[2]   Tumor-associated transforming growth factor-β and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients [J].
Bellone, G ;
Turletti, A ;
Artusio, E ;
Mareschi, K ;
Carbone, A ;
Tibaudi, D ;
Robecchi, A ;
Emanuelli, G ;
Rodeck, U .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (02) :537-547
[3]  
BURR ML, 1993, MONOGR ALLERGY, V31, P1
[4]   Predictors of pancreatic cancer mortality among a large cohort of United States adults [J].
Coughlin, SS ;
Calle, EE ;
Patel, AV ;
Thun, MJ .
CANCER CAUSES & CONTROL, 2000, 11 (10) :915-923
[5]   PRIOR IMMUNITY-RELATED MEDICAL CONDITIONS AND PANCREATIC-CANCER RISK IN SHANGHAI [J].
DAI, Q ;
ZHENG, W ;
JI, BT ;
SHU, XO ;
JIN, F ;
ZHU, JL ;
GAO, YT .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (03) :337-340
[6]   ASPECTS OF MEDICAL HISTORY AND EXOCRINE CARCINOMA OF THE PANCREAS - A POPULATION-BASED CASE-CONTROL STUDY IN THE NETHERLANDS [J].
DEMESQUITA, HBB ;
MAISONNEUVE, P ;
MOERMAN, CJ ;
WALKER, AM .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (01) :17-23
[7]  
Duell EJ, 2002, CANCER RES, V62, P4630
[8]   A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk [J].
Duell, EJ ;
Holly, EA ;
Bracci, PM ;
Liu, M ;
Wiencke, JK ;
Kelsey, KT .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (04) :297-306
[9]   A PROSPECTIVE-STUDY OF CANCER INCIDENCE IN A COHORT EXAMINED FOR ALLERGY [J].
ERIKSSON, NE ;
HOLMEN, A ;
HOGSTEDT, B ;
MIKOCZY, Z ;
HAGMAR, L .
ALLERGY, 1995, 50 (09) :718-722
[10]   DIABETES-MELLITUS AS A RISK FACTOR FOR PANCREATIC-CANCER - A METAANALYSIS [J].
EVERHART, J ;
WRIGHT, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (20) :1605-1609